(4S)-6-Chloro-4-[(1E)-2-cyclopropylethenyl]-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one
CAS : 440124-96-9
Ref. 3D-FC102842
1mg | Arrêté | ||
2mg | Arrêté | ||
5mg | Arrêté | ||
10mg | Arrêté | ||
25mg | Arrêté |
Informations sur le produit
Efavirenz is a non-nucleoside reverse transcriptase inhibitor. It is used to treat HIV infection and AIDS. Efavirenz has been shown to be an impurity in the synthesis of 6-chloro-4-[(1E)-2-cyclopropylethenyl]-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one. The impurities are removed by a deprotection reaction that removes the protecting group from the molecule.